Asbestosis Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
Conditions: Advanced Cancer; Advanced Solid Tumor; Neoplasm Malignant; Metastatic Cancer; Melanoma; Classical Hodgkin Lymphoma; Non Small Cell Lung Cancer; Renal Cell Carcinoma; Urothelial Carcinoma; Head and Neck Squamous Cell Carcinoma; Subungual Squamous Cell Carcinoma; Oesophageal Carcinoma; MSI-H Colorectal Cancer; Gastric Cancer; Triple Negative Breast Cancer; Endometrial Carcinoma; Pleural Mesothelioma Interventions: Drug: Fosifloxuridine Nafalbenamide; Drug: Leucovorin; Drug: Pembrolizumab; Drug: Docetaxel Sponsor: �...
Source: ClinicalTrials.gov - February 6, 2023 Category: Research Source Type: clinical trials

Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma
Conditions: Advanced Renal Cell Carcinoma; Advanced Mesothelioma; Advanced Osteosarcoma Interventions: Drug: CAR.70/IL15-transduced CB-derived NK cells; Drug: Fludarabine phosphate; Drug: Cyclophosphamide Sponsor: M.D. Anderson Cancer Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 30, 2023 Category: Research Source Type: clinical trials